Absci (ABSI) Other financing activities (2024 - 2026)
Absci (ABSI) posted Other financing activities of $59000.0 for Q1 2026, down 93.0% sequentially from $843000.0 in Q4 2025, and down 96.92% YoY from $1.9 million in Q1 2025.
Absci (ABSI) Other financing activities (2024 - 2026) Analysis & Trends
Absci has reported Other financing activities for 3 years, with the latest figure at $59000.0 in Q1 2026.
- Quarterly Other financing activities fell 96.92% year-over-year to $59000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 67.25% YoY) and the FY2025 annual result came in at $3.3 million, down 20.41% from the prior year.
- Other financing activities eased to $59000.0 in Q1 2026 per ABSI's latest filing, from $843000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $4.2 million in Q4 2024 and troughed at -$1.6 million in Q2 2024.
- A 3-year average of $941000.0 and a median of $647000.0 in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2025 and 2026: Other financing activities surged 106.26% in 2025, then tumbled 96.92% in 2026.
- Over 3 years, Other financing activities stood at $4.2 million in 2024, then tumbled by 79.73% to $843000.0 in 2025, then slumped by 93.0% to $59000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $59000.0, $843000.0, and $451000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Jun 30, 2026 | 4.85 Mn |
| Mar 31, 2026 | 59,000.00 |
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.63 Mn |